Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats.
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies.
Remyelination after Lysophosphatidyl Choline-Induced Demyelination Is Stimulated by Bone Marrow Stromal Cell-Derived Oligoprogenitor Cell Transplantation.
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
Familial comorbidity of bipolar disorder and multiple sclerosis: Genetic susceptibility, coexistence or causal relationship?
The cuprizone model: regional heterogeneity of pathology.
Neutralizing Nanobodies targeting diverse chemokines effectively inhibit chemokine function.
Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis.
Prevalence and clinical features of multiple sclerosis in Latin America.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
A phase-specific neuroimmune model of clinical depression.
Barriers to investigator-initiated deep brain stimulation and device research.
Association Between MTHFR Genetic Variants and Multiple Sclerosis in a Southern Iranian Population.
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.
Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
Psychometric Properties of the Arab Heritage Activity Card Sort.
Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Immunological differences between classical phenothypes of multiple sclerosis.
Pages
« first
‹ previous
…
218
219
220
221
222
223
224
225
226
…
next ›
last »